A Study to Comparing SCD411 and Eylea® in Subjects With Wet Age-related Macular Degeneration (AMD)
Clinical trial NCT04480463 · COMPLETED
Trial details
- NCT number
- NCT04480463
- Sponsor
- Sam Chun Dang Pharm. Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-13
- Primary completion
- 2022-09-08
- Enrollment
- 576
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.